These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30483391)

  • 1. Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells.
    Jafari-Gharabaghlou D; Pilehvar-Soltanahmadi Y; Dadashpour M; Mota A; Vafajouy-Jamshidi S; Faramarzi L; Rasouli S; Zarghami N
    Iran J Basic Med Sci; 2018 Nov; 21(11):1167-1173. PubMed ID: 30483391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Anti-proliferative Effects of Metformin and Silibinin Combination on T47D Breast Cancer Cells via hTERT and Cyclin D1 Inhibition.
    Chatran M; Pilehvar-Soltanahmadi Y; Dadashpour M; Faramarzi L; Rasouli S; Jafari-Gharabaghlou D; Asbaghi N; Zarghami N
    Drug Res (Stuttg); 2018 Dec; 68(12):710-716. PubMed ID: 29920623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
    Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells.
    Javan Maasomi Z; Pilehvar Soltanahmadi Y; Dadashpour M; Alipour Sh; Abolhasani S; Zarghami N
    Asian Pac J Cancer Prev; 2017 May; 18(5):1283-1287. PubMed ID: 28610415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression.
    Rasouli S; Zarghami N
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):977-982. PubMed ID: 29693804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells.
    Abdulkareem SJ; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Salmani-Javan E; Toroghi F; Zarghami N
    Daru; 2024 Jun; 32(1):133-144. PubMed ID: 38168007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells.
    Salmani-Javan E; Jafari-Gharabaghlou D; Bonabi E; Zarghami N
    Front Oncol; 2023; 13():1193708. PubMed ID: 37664043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
    Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
    Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
    Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
    PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment.
    Khoshravan L; Dadashpour M; Hashemi M; Zarghami N
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):919-927. PubMed ID: 35345364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.
    Ayoub NM; Al-Shami KM; Alqudah MA; Mhaidat NM
    Onco Targets Ther; 2017; 10():4869-4883. PubMed ID: 29042798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Farghadani R; Seifaddinipour M; Rajarajeswaran J; Abdulla MA; Mohd Hashim NB; Khaing SL; Salehen NB
    PeerJ; 2019; 7():e7686. PubMed ID: 31608167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
    Ariaans G; Jalving M; Vries EG; Jong S
    BMC Cancer; 2017 Mar; 17(1):232. PubMed ID: 28356082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells.
    Menéndez JA; del Mar Barbacid M; Montero S; Sevilla E; Escrich E; Solanas M; Cortés-Funes H; Colomer R
    Eur J Cancer; 2001 Feb; 37(3):402-13. PubMed ID: 11239764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.